[Federal Register Volume 68, Number 72 (Tuesday, April 15, 2003)]
[Notices]
[Page 18262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-9227]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 25, 2002, Cody 
Laboratories, Inc., 331 33rd Street, Cody, Wyoming 82414, made 
application by renewal, and on March 5, 2003, by letter to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of Schedule II of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  II
Methamphetamine (1105).....................  II
Amphetamine (1100).........................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Phenylacetone (8501).......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to produce bulk products for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Drug Operations Section, Domestic Drug 
Unit (ODOD) and must be filed no later than June 16, 2003.

    Dated: April 3, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-9227 Filed 4-14-03; 8:45 am]
BILLING CODE 4410-09-M